Tag: Selumetinib

Feb 13th – Published today, 8 out of 20 patients with metastatic thyroid cancer refractory to radioiodine therapy trapped therapeutic doses of radioiodine after administration of Selumetinib. Image: PD 1. 8 out of 20 patients with metastatic thyroid cancer refractory to radioiodine therapy trapped therapeutic doses of radioiodine after administration of Selumetinib. 2. 7...